HTHitoshi Tsuda

Hitoshi Tsuda

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hitoshi Tsuda has a total of 61 co-authors. Here are the top co-authors by number of shared publications:

  • Takashi Fukutomi

    From the Pathology Division* and Department of Surgery,‡ National Cancer Center Research Institute and Hospital, Tokyo; and the Department of Pathology II,† National Defense Medical College, Saitama, Japan

    5 shared publications
  • Futoshi Akiyama

    Pathology Division, Cancer Institute and Departments of

    4 shared publications
  • Setsuo Hirohashi

    From the Pathology Division* and Department of Surgery,‡ National Cancer Center Research Institute and Hospital, Tokyo; and the Department of Pathology II,† National Defense Medical College, Saitama, Japan

    4 shared publications
  • Tadashi Hasegawa

    Pathology Division, National Cancer Center Research Institute, Tokyo

    4 shared publications
  • Takahiro Kasamatsu

    Gynecologic Oncology, National Cancer Center Hospital, Tokyo, Japan

    4 shared publications
  • Teruko Takarabe

    From the Pathology Division* and Department of Surgery,‡ National Cancer Center Research Institute and Hospital, Tokyo; and the Department of Pathology II,† National Defense Medical College, Saitama, Japan

    4 shared publications

Latest Publications

  • Reproducible and clinically meaningful differential diagnosis is possible between lobular endocervical glandular hyperplasia and ‘adenoma malignum’ based on common histopathological criteria

    by Hitoshi Tsuda, Yoshiki Mikami, Tsunehisa Kaku, Tadashi Hasegawa, Futoshi Akiyama, Yoshihiro Ohishi, Yuko Sasajima, Takahiro Kasamatsu

    The aim of the present study was to determine if the differential diagnosis between lobular endocervical glandular hyperplasia (LEGH) and minimal deviation adenocarcinoma (MDA), or ‘adenoma malignum’, is reproducible when clear criteria for these two lesions are given. A total of 44 proliferative endocervical glandular lesions were collected, for which differential diagnosis from MDA was considered to be necessary. Seven observers independently classified these 44 lesions into LEGH, LEGH with adenocarcinoma in situ (AIS), MDA, or common cervical adenocarcinoma, according to the following criteria: LEGH was non‐invasive proliferation of endocervical glandular cells without any obvious adenocarcinoma component. MDA was very well‐differentiated endocervical‐type mucinous adenocarcinoma composed mostly of LEGH‐looking glands but containing the component of obviously invasive adenocarcinoma. LEGH with AIS was defined as continuous coexistence of LEGH and AIS. Among these four diagnostic categories, the interobserver agreement level was substantial (κ = 0.618). The level increased to almost perfect (κ = 0.928) between the group of non‐invasive lesions consisting of LEGH and LEGH with AIS and the other group of invasive lesions comprising MDA and common adenocarcinoma. When the modal diagnosis was adopted as the final diagnosis for individual lesions, the 5 year survival rate of patients after surgery was 100% for the non‐invasive lesions but only 54% for the invasive lesions (P < 0.01). It is clearly shown that reproducible differential diagnosis is possible between LEGH, LEGH with AIS, and MDA and that such a differentiation is clinically meaningful.


  • Open Access

    Correlation of KIT and EGFR overexpression with invasive ductal breast carcinoma of the solid‐tubular subtype, nuclear grade 3, and mesenchymal or myoepithelial differentiation

    by Hitoshi Tsuda, Daisaku Morita, Mikihiko Kimura, Eiji Shinto, Yukiko Ohtsuka, Osamu Matsubara, Johji Inazawa, Kuniyoshi Tamaki, Hidetaka Mochizuki, Seiichi Tamai, et al.

    Although KIT and EGFR overexpressions are reported to occur in breast cancer, their pathological significance is still unclear. We examined KIT, EGFR, and c‐erbB‐2 overexpressions immunohistochemically in 150 cases of surgically resected breast cancer and their correlation with the histological type and grade and mesenchymal and/or myoepithelial immunophenotype of primary tumors. To facilitate the analysis, we constructed a tissue microarray comprising 2‐mm diameter tissues cored from the representative tissue block of each tumor. KIT, EGFR, and c‐erbB‐2 overexpressions were detected in 15 (10%), 12 (8%), and 23 (15%), respectively. The KIT was more frequent in the group comprising comedo‐type ductal carcinoma in situ and invasive ductal carcinomas (IDCs) of the solid‐tubular subtype than in the group of other histological types (P = 0.027), and the EGFR was more frequent in IDCs of solid‐tubular type than in other histological types (P < 0.05). KIT and EGFR overexpressions were correlated with nuclear grade 3 (P = 0.0095 and 0.0005) and tended to be concurrent (P = 0.005). KIT overexpression was correlated with vimentin and S‐100 expression (P = 0.003 and P = 0.005), and EGFR overexpression was correlated with S100 expression (P = 0.0001). These correlations with grade and mesenchymal/myoepithelial markers were not observed for c‐erbB‐2 overexpression. KIT and EGFR appeared to be indicators of high‐grade breast carcinoma groups that often contain the carcinomas with mesenchymal and/or myoepithelial differentiation, which are distinct from the group with c‐erbB‐2 overexpression. (Cancer Sci 2005; 96: 48 –53)


  • Reproducible Immunohistochemical Criteria Based on Multiple Raters’ Judgments for Expression of Thymidine Phosphorylase in Breast Cancer Tissue

    by Hitoshi Tsuda, Futoshi Akiyama, Masafumi Kurosumi, Goi Sakamoto

    In order to accurately determine the expression of thymidine phosphorylase (TP) in breast cancer, it is important to develop an appropriate system for immunohistochemical staining evaluation. Three raters, pathologists A–C, independently judged the status of TP in both cancer cells and cancer stromal tissue in 586 breast cancers immunohistochemically. TP expression levels were categorized into four groups (scores 0–3), and scores of 2 and 3 were considered as positive. Interrater and intrarater agreement levels in the judgment of TP expression were analyzed by the kappa statistics. By combining three raters’ judgments, we sought for the optimal evaluation system that generates the best concordance among all judgments. The numbers of TP-positive cases were 294 (50.2%), 309 (52.1%) and 344 (58.7%) for cancer cells and were 315 (53.8%), 383 (65.4%) and 397 (67.7%) for cancer stromal tissue in the judgments by pathologists A, B, and C, respectively. There was no correlation of TP immunostaining between cancer cells and cancer stroma tissue. Interrater agreement levels were substantial for cancer cells (κ= 0.652) and moderate for cancer stroma tissue (κ= 0.438). Intrarater agreement level for TP judgment by pathologists A, B, or C was substantial to almost perfect for cancer cells (κ= 0.755–0.880), and for cancer stromal tissue (κ= 0.620–0.752). The level of TP expression estimated under the majority system and the total scoring system setting a cut-off score between 4 and 5 revealed the highest concordance with the three raters’ judgments. To accurately evaluate the TP status in breast cancer tissue, three or more raters are needed and the majority system and total scoring system appear appropriate.


  • A proposal for diagnostically meaningful criteria to classify increased epidermal growth factor receptor and c-erbB-2 gene copy numbers in gastric carcinoma, based on correlation of fluorescence in situ hybridization and immunohistochemical measurements

    by Mikihiko Kimura, Hitoshi Tsuda, Daisaku Morita, Takashi Ichikura, Sho Ogata, Shinsuke Aida, Yutaka Yoshizumi, Tadaaki Maehara, Hidetaka Mochizuki, Osamu Matsubara

    Amplification of the epidermal growth factor receptor (EGFR) and/or c-erbB-2 oncogenes and overexpression of their proteins are detected in 30% of gastric carcinomas, but there are few reports regarding the correlation between gene amplification and protein overexpression. We examined the correlation between amplification of the EGFR and c-erbB-2 genes, detected using fluorescence in situ hybridization, and overexpression of their proteins, detected using immunohistochemistry, in formalin-fixed tissue sections of 54 surgically resected gastric carcinomas. A mean EGFR copy number per nucleus of four or more and an EGFR/chromosome 7 centromere (CEP7) ratio of 1.7 or more were each detected in 4 specimens (7%). The sensitivity and specificity of both criteria for EGFR protein overexpression were 75% and 92%, respectively. A mean c-erbB-2 copy number per nucleus of 7.0 or more and a c-erbB-2/chromosome 17 centromere (CEP17) ratio of 2.0 or more were detected in six (11%) and eight (15%) specimens, respectively. The sensitivity and specificity of the former criterion to c-erbB-2 overexpression were 83% and 98%, respectively, while those of the latter were 63% and 98%. A mean EGFR gene copy number of 4.0 or more and/or an EGFR/CEP7 ratio of 1.7 and a mean c-erbB-2 gene copy number of 7.0 or more and/or a c-erbB-2/CEP17 ratio of 2.0 or more would be useful in defining increased EGFR and c-erbB-2 gene copy numbers, respectively, in gastric carcinomas.


  • Open Access

    Different expression patterns of KIT, EGFR, and HER‐2 (c‐erbB‐2) oncoproteins between epithelial and mesenchymal components in uterine carcinosarcoma

    by Morio Sawada, Hitoshi Tsuda, Mikihiko Kimura, Sanshiro Okamoto, Tsunekazu Kita, Takahiro Kasamatsu, Takuro Yamada, Yoshihiro Kikuchi, Hideo Honjo, Osamu Matsubara

    Uterine carcinosarcoma histologically comprises the components of epithelial and mesenchymal malignancies, and is known to be clinically highly aggressive. To reveal the significance of the expression of tyrosine‐kinase‐receptor‐type oncoproteins in this tumor type, the incidence and distribution of the KIT, EGFR, and HER‐2 (c‐erbB‐2) oncoproteins were immunohistochemically examined in 16 surgically resected cases. For 6 cases, the EGFR and HER‐2 amplifications were also examined by fluorescence in situ hybridization (FISH). In the epithelial component, overexpressions of KIT, EGFR, and HER‐2 were detected in 4 (25%), 5 (31%), and 9 (56%) cases, respectively, whereas these overexpressions in the mesenchymal component were detected in 6 (38%), 8 (50%), and 1 (6%) cases, respectively. KIT and EGFR were co‐overexpressed in the mesenchymal component of 4 cases and in the epithelial component of 2 cases. However, HER‐2 overexpression was mostly detected in the epithelial component only, and tended to occur independently of KIT and/or EGFR overexpression. By FISH, one of the 4 cases with HER‐2 overexpression showed low‐level gene amplification. In two cases with EGFR overexpression, the gain of EGFR alleles and/or polyploidization of chromosome 7 had occurred. The expression patterns of KIT, EGFR, and HER‐2 differed between the epithelial and mesenchymal components, and the regulation of their expression appeared important in the acquisition of mesenchymal metaplasia in uterine carcinosarcoma. Structural and/or numerical alterations of chromosomes might be in part involved in EGFR and/or HER‐2 overexpression in this tumor type.


  • Interobserver variation in the diagnosis of adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervix

    by Hitoshi Tsuda, Yoshiki Mikami, Tsunehisa Kaku, Futoshi Akiyama, Tadashi Hasegawa, Satoshi Okada, Isamu Hayashi, Takahiro Kasamatsu

    To examine the interobserver agreement level of the histological diagnosis of adenoma malignum (ADM), 52 proliferative endocervical glandular lesions were evaluated independently by four observers (A to D), each of whom is in charge of gynecological pathology at a different hospital. The correlation of diagnosis by each observer with patient outcome was also examined for 19 of these lesions. When the diagnoses were categorized into benign lesions including hyperplasias, ADM, and common types of adenocarcinoma, consistent diagnoses among all observers were achieved for only 12 lesions (23%), with a slight level of interobserver agreement (κ = 0.115). The points of disagreement were as follows: (i) whether proliferative endocervical glandular lesions preserving lobular structures were diagnosed as benign or as ADM; and (ii) whether proliferative endocervical glandular lesions with a discrete area of obvious adenocarcinoma were diagnosed as ADM or as common‐type adenocarcinoma. The mortality rates of patients with ADM diagnosed by observers A, B, C, and D were 60% (3 of 5), 25% (3 of 12), 14% (1 of 7), and 13% (2 of 15), respectively. Therefore, ADM diagnosed by observers A and B was frequently lethal, whereas ADM diagnosed by observers C and D was mostly non‐lethal and might contain benign lesions. The diagnosis of ADM covered various spectra of proliferative endocervical glandular lesions among the observers. Disagreement in the diagnosis was suggested to derive largely from the absence of consensus criteria for differential diagnosis among benign hyperplastic lesions, ADM, and common adenocarcinoma, and from differences in the observers’ interpretations about cellular atypia and invasion.


  • Immature glandular features in squamous cell carcinoma of the uterine cervix as an independent indicator of resistance to radiotherapy

    by S. Okada, H. Tsuda, K. Ohmi, T. Kasamatsu, T. Yamada, R. Tsunematsu, M. Sumi, K. Tokuuye, H. Yoshikawa, S. Hirohashi

    Okada S, Tsuda H, Ohmi K, Kasamatsu T, Yamada T, Tsunematsu R, Sumi M, Tokuuye K, Yoshikawa H, Hirohashi S. Immature glandular features in squamous cell carcinoma of the uterine cervix as an independent indicator of resistance to radiotherapy. The aim of this study was to evaluate the significance of “immature glandular features” in cervical squamous cell carcinoma (SCC) as an indicator of tumor radioresistance. Pretreatment biopsied tissue specimens of cervical SCC from 100 patients who were uniformly treated with radiotherapy alone were classified into clinically radioresistant (cR) and radiosensitive (cS) groups. Seven histologic parameters comprising glassy cells, signet ring cells, squamous differentiation, recognizable gland, nuclear atypia, stromal response, and mitotic counts were examined. Glassy cells and signet ring cells were regarded as “immature glandular features”. The correlation of these seven parameters with tumor response to radiotherapy and patient prognosis was analyzed by univariate and multivariate analyses. As objective indicators of glandular differentiation, alcian‐blue staining and immunostaining of cytokeratins 7 and 20 were also performed. It was revealed that immature glandular features, absence of squamous differentiation, and low nuclear atypia were significant indicators of radioresistance of the tumor and of poorer patient prognosis. Combining those histological parameters, the present SCC cases were classified into 26 pathologically radioresistant (pR) and 74 radiosensitive (pS) groups. In the pR group, 54% (14 of 26) were clinically radioresistant, whereas 20% (15 of 74) of the pS group were clinically radioresistant (P = 0.002). The overall prognosis of the pR group was much poorer than that of the pS group (P < 0.0001). This correlation also held true in cases of identical stage and age. We could not show objectively glandular differentiation of “immature glandular features”. Nonetheless, the identification of “immature glandular features” was effective in predicting the radiotherapy resistance of cervical SCC and poorer patient prognosis.


  • Invasive ductal carcinoma associated with tubular adenoma of the breast

    by Hideharu Domoto, Hitoshi Tsuda, Kunihisa Miyakawa, Akiko Shinoda, Takeshi Nanasawa

    We report an extremely rare case of the colocalization of a tubular adenoma and an invasive ductal carcinoma occurring in a 55‐year‐old woman. Following radiographical evaluation, fine‐needle aspiration cytology of the left breast tumor was undertaken. Because cytological examination revealed malignancy, a partial mastectomy was performed. Histologically, the tumor (measuring 1.7 × 1.3 cm) comprised two distinct parts: tubular adenoma and invasive ductal carcinoma. The invasive ductal carcinoma showed a solid pattern, high nuclear and structural atypia and frequent mitotic figures, while the tubular adenoma consisted of a proliferation of small ducts lined by single layers of epithelial and myoepithelial cells with bland nuclei and inconspicuous nucleoli. The histological boundary was clearly defined between the tubular adenoma and the invasive ductal carcinoma, and between the tubular adenoma and the surrounding breast tissue. The current case might be a collision between separate tubular adenoma and invasive ductal carcinoma, but the malignant transformation of a tubular adenoma cannot be ruled out. Both the long‐term observation of this case and analysis of more cases may enable us to determine the histological characteristics and clinical significance of invasive ductal carcinoma associated with tubular adenoma.


  • Open Access

    Different pattern of loss of heterozygosity among endocervical‐type adenocarcinoma, endometrioid‐type adenocarcinoma and adenoma malignum of the uterine cervix

    by Hitoshi Tsuda, Teruko Takarabe, Satoshi Okada, Hiroshi Uchida, Takahiro Kasamatsu, Takuro Yamada, Ryuichiro Tsunematsu, Kazuo Ohmi, Setsuo Hirohashi

    It is unclear which chromosome arms frequently show loss of heterozygosity (LOH) in adenocarcinoma of the uterine cervix. To identify such chromosomal arms, LOH on 52 different chromosome loci was examined using laser capture microdissection and PCR‐LOH analysis in 25 common‐type adenocarcinomas, comprising 13 cases of endocervical type, 12 cases of endometrioid type and 7 cases of adenoma malignum without the component of conventional endocervical‐type adenocarcinoma (designated as “pure” form). In adenocarcinomas of endocervical type and endometrioid type, LOH was commonly detected on chromosome arms 17p (62% and 50%, respectively), 1p (33% and 67%) and 22q (40% and 33%). In addition, endocervical‐type adenocarcinoma frequently (≥30%) showed LOH on 18p (71%), 19q (50%), 19p (38%) and 16q (38%), whereas endometrioid‐type adenocarcinoma frequently showed LOH on 10q (43%) and 5q (40%). LOH was only sporadically detected on 9q, 18q, or 21q in 3 of 7 cases of “pure” adenoma malignum. In a case of coexistence of “pure” adenoma malignum and adenocarcinoma in situ (AIS), LOH on 1q, 5p, 11p, 17p, 18p and 18q was detected only in AIS. LOH was accumulated on a number of chromosome arms in the adenocarcinoma at the early developmental stage before stromal invasion. Chromosomal arms that are prone to show LOH appeared to differ between the 2 types of cervical adenocarcinoma. We could suggest that “pure” adenoma malignum is of clonal and neoplastic nature in view of the detection of LOH.